English | Español
Patient Daily | Jan 7, 2026

Biotech investors expect rebound by 2026 amid rising deal activity
Patient Daily | Jan 7, 2026

FDA rejects Corcept and Outlook drug applications; stocks fall sharply
Patient Daily | Jan 7, 2026

Big pharma leads Q4 biopharma M&A as smaller biotech deals gain momentum
Patient Daily | Jan 7, 2026

HiArc announces launch of first commercial product at MD&M West 2026
Patient Daily | Jan 7, 2026

Ultragenyx faces setback as key bone drug fails late-stage trial
Patient Daily | Jan 7, 2026

Pfizer leads U.S. drugmakers in planned price increases for 2026
Patient Daily | Jan 7, 2026

Study finds Milan’s Linate Airport is a significant source of airborne tire-related pollutants
Patient Daily | Jan 7, 2026

FDA approves Vanda's Nereus as first new motion sickness drug in four decades

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'